Correlating Continuously Captured Home-based Digital Biomarkers of Daily Function with Postmortem Neurodegenerative Neuropathology

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2023 Jun 8

PMID 37289845

Authors

Nathan C Hantke

Jeffrey Kaye

Nora Mattek

Chao-Yi Wu

Hiroko H Dodge

Zachary Beattie

Randy Woltjer

Affiliations

Soon will be listed here.

Abstract

Background: Outcome measures available for use in Alzheimer's disease (AD) clinical trials are limited in ability to detect gradual changes. Measures of everyday function and cognition assessed unobtrusively at home using embedded sensing and computing generated "digital biomarkers" (DBs) have been shown to be ecologically valid and to improve efficiency of clinical trials. However, DBs have not been assessed for their relationship to AD neuropathology.

Objectives: The goal of the current study is to perform an exploratory examination of possible associations between DBs and AD neuropathology in an initially cognitively intact community-based cohort.

Methods: Participants included in this study were ≥65 years of age, living independently, of average health for age, and followed until death. Algorithms, run on the continuously-collected passive sensor data, generated daily metrics for each DB: cognitive function, mobility, socialization, and sleep. Fixed postmortem brains were evaluated for neurofibrillary tangles (NFTs) and neuritic plaque (NP) pathology and staged by Braak and CERAD systems in the context of the "ABC" assessment of AD-associated changes.

Results: The analysis included a total of 41 participants (M±SD age at death = 92.2±5.1 years). The four DBs showed consistent patterns relative to both Braak stage and NP score severity. Greater NP severity was correlated with the DB composite and reduced walking speed. Braak stage was associated with reduced computer use time and increased total time in bed.

Discussion: This study provides the first data showing correlations between DBs and neuropathological markers in an aging cohort. The findings suggest continuous, home-based DBs may hold potential to serve as behavioral proxies that index neurodegenerative processes.

References

Ferman T, Boeve B, Smith G, Lin S, Silber M, Pedraza O . Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology. 2011; 77(9):875-82. PMC: 3162640. DOI: 10.1212/WNL.0b013e31822c9148. View

Seelye A, Mattek N, Howieson D, Austin D, Wild K, Dodge H . Embedded Online Questionnaire Measures Are Sensitive to Identifying Mild Cognitive Impairment. Alzheimer Dis Assoc Disord. 2015; 30(2):152-9. PMC: 4715793. DOI: 10.1097/WAD.0000000000000100. View

Serrano-Pozo A, Qian J, Muzikansky A, Monsell S, Montine T, Frosch M . Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum. J Neuropathol Exp Neurol. 2016; 75(6):516-26. PMC: 6250207. DOI: 10.1093/jnen/nlw026. View

Kaye J, Mattek N, Dodge H, Campbell I, Hayes T, Austin D . Unobtrusive measurement of daily computer use to detect mild cognitive impairment. Alzheimers Dement. 2013; 10(1):10-7. PMC: 3872486. DOI: 10.1016/j.jalz.2013.01.011. View

Farias S, Mungas D, Reed B, Cahn-Weiner D, Jagust W, Baynes K . The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology. 2008; 22(4):531-44. PMC: 2877034. DOI: 10.1037/0894-4105.22.4.531. View

Seelye A, Hagler S, Mattek N, Howieson D, Wild K, Dodge H . Computer mouse movement patterns: A potential marker of mild cognitive impairment. Alzheimers Dement (Amst). 2016; 1(4):472-480. PMC: 4748737. DOI: 10.1016/j.dadm.2015.09.006. View

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34(7):939-44. DOI: 10.1212/wnl.34.7.939. View

Wang C, Holtzman D . Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors. Neuropsychopharmacology. 2019; 45(1):104-120. PMC: 6879647. DOI: 10.1038/s41386-019-0478-5. View

Lussier M, Lavoie M, Giroux S, Consel C, Guay M, Macoir J . Early Detection of Mild Cognitive Impairment With In-Home Monitoring Sensor Technologies Using Functional Measures: A Systematic Review. IEEE J Biomed Health Inform. 2018; 23(2):838-847. DOI: 10.1109/JBHI.2018.2834317. View

10.

Dodge H, Zhu J, Mattek N, Austin D, Kornfeld J, Kaye J . Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials. PLoS One. 2015; 10(9):e0138095. PMC: 4574479. DOI: 10.1371/journal.pone.0138095. View

11.

Hayes T, Riley T, Mattek N, Pavel M, Kaye J . Sleep habits in mild cognitive impairment. Alzheimer Dis Assoc Disord. 2013; 28(2):145-50. PMC: 3990656. DOI: 10.1097/WAD.0000000000000010. View

12.

Silbert L, Dodge H, Lahna D, Promjunyakul N, Austin D, Mattek N . Less Daily Computer Use is Related to Smaller Hippocampal Volumes in Cognitively Intact Elderly. J Alzheimers Dis. 2016; 52(2):713-7. PMC: 4866889. DOI: 10.3233/JAD-160079. View

13.

Ju Y, McLeland J, Toedebusch C, Xiong C, Fagan A, Duntley S . Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013; 70(5):587-93. PMC: 3676720. DOI: 10.1001/jamaneurol.2013.2334. View

14.

Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

15.

Hebert L, Weuve J, Scherr P, Evans D . Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013; 80(19):1778-83. PMC: 3719424. DOI: 10.1212/WNL.0b013e31828726f5. View

16.

Kaye J, Mattek N, Dodge H, Buracchio T, Austin D, Hagler S . One walk a year to 1000 within a year: continuous in-home unobtrusive gait assessment of older adults. Gait Posture. 2011; 35(2):197-202. PMC: 3278504. DOI: 10.1016/j.gaitpost.2011.09.006. View

17.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

18.

Kaye J, Maxwell S, Mattek N, Hayes T, Dodge H, Pavel M . Intelligent Systems For Assessing Aging Changes: home-based, unobtrusive, and continuous assessment of aging. J Gerontol B Psychol Sci Soc Sci. 2011; 66 Suppl 1:i180-90. PMC: 3132763. DOI: 10.1093/geronb/gbq095. View

19.

Piau A, Wild K, Mattek N, Kaye J . Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review. J Med Internet Res. 2019; 21(8):e12785. PMC: 6743264. DOI: 10.2196/12785. View

20.

Mirra S, HEYMAN A, McKeel D, SUMI S, Crain B, Brownlee L . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991; 41(4):479-86. DOI: 10.1212/wnl.41.4.479. View